🇺🇸 FDA
Patent

US 8349838

Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

granted A61KA61K31/502A61P

Quick answer

US patent 8349838 (Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61K, A61K31/502, A61P, A61P13/12, A61P15/00